F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
serum total cholesterol level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood cholesterol amount |
male |
218 days
| 11 |
|
76.2 |
mg/dl |
1.79 |
5.94 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
|
12799 |
311 |
SHR/Izm |
serum total cholesterol level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (for 70 days) then fasting |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood cholesterol amount |
male |
98 days
| 10 |
|
49.5 |
mg/dl |
2.12 |
6.7 |
serum total cholesterol measurement test |
|
|
|
0 |
|
|
|
12447 |
263 |
DA/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood cholesterol amount |
female |
196 days-224 days |
12 |
serial mean |
115.83 |
mg/dl |
|
|
serum total cholesterol measurement test |
ophthalmic venous plexus |
|
|
0 |
|
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
12426 |
251 |
MWF/FubRkb |
serum total cholesterol level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood cholesterol amount |
not specified |
168 days
| 18 |
|
122.01 |
mg/dl |
6.95 |
29.49 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
serum triglyceride analysis |
|
65391 |
117 |
SHRSP/Izm |
serum total cholesterol level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood cholesterol amount |
male |
91 days
| 5 |
|
54.83 |
mg/dl |
1.93 |
4.32 |
serum total cholesterol measurement test |
|
0 |
|
0 |
|
|
|
64850 |
115 |
SHRSP.WKY-(Klk1-D1Rat116)/Izm |
serum total cholesterol level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood cholesterol amount |
male |
91 days
| 5 |
|
49.42 |
mg/dl |
3.86 |
8.63 |
serum total cholesterol measurement test |
|
0 |
|
0 |
|
|
|
64851 |
115 |
SHRSP.WKY-(Klk1-D1Rat116)/Izm |
serum total cholesterol level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood cholesterol amount |
female |
91 days
| 5 |
|
65.64 |
mg/dl |
1.93 |
4.32 |
serum total cholesterol measurement test |
|
0 |
|
0 |
|
|
|
64854 |
115 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
7 |
|
42.69 |
mg/dl |
5.25 |
13.89 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
97747 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
10 |
|
277.94 |
mg/dl |
40.79 |
128.99 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
97749 |
1918 |
WKY |
serum total cholesterol level |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood cholesterol amount |
male |
0 days
| 12 |
|
88.0 |
mg/dl |
5.0 |
17.32 |
serum total cholesterol measurement test |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
|
100407 |
2479 |
WKY |
serum total cholesterol level |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood cholesterol amount |
male |
0 days
| 11 |
|
240.0 |
mg/dl |
15.0 |
49.75 |
serum total cholesterol measurement test |
|
0.0 |
PA IV 50mg/kg |
19 |
days |
|
|
100404 |
2479 |
SHRSP/A3N |
serum total cholesterol level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood cholesterol amount |
male |
120 days-140 days |
24 |
|
87.0 |
mg/dl |
2.0 |
9.8 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
107624 |
3093 |
BN/Seac |
serum total cholesterol level |
control condition |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood cholesterol amount |
male |
28 days
| 11 |
|
104.0 |
mg/dl |
3.1 |
10.28 |
serum total cholesterol measurement test |
|
|
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
|
13138 |
71 |
SHRSP/Izm |
serum total cholesterol level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood cholesterol amount |
female |
91 days
| 5 |
|
67.57 |
mg/dl |
2.32 |
5.18 |
serum total cholesterol measurement test |
|
0 |
|
0 |
|
|
|
64853 |
115 |
WKY |
serum total cholesterol level |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood cholesterol amount |
male |
0 days
| 11 |
|
73.0 |
mg/dl |
7.0 |
23.22 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
100406 |
2479 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
serum total cholesterol level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood cholesterol amount |
male |
218 days
| 7 |
|
65.8 |
mg/dl |
2.93 |
7.75 |
serum total cholesterol measurement test |
|
0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
|
12787 |
311 |
SHRSP/A3 |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
female |
112 days
| 5 |
|
55.72 |
mg/dl |
0.62 |
1.38 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
68956 |
1033 |
WKY |
serum total cholesterol level |
controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood cholesterol amount |
male |
0 days
| 12 |
|
104.0 |
mg/dl |
10.0 |
34.64 |
serum total cholesterol measurement test |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
|
100408 |
2479 |
FHH-Nr4a1m1Mcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
56 days
| 6 |
|
71.0 |
mg/dl |
2.1 |
5.14 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
99502 |
2318 |
FHH-Nr4a1m1Mcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
112 days
| 6 |
|
122.0 |
mg/dl |
8.7 |
21.31 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
99504 |
2318 |
SS.ZUC-Leprfa-/-/Slc |
serum total cholesterol level |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood cholesterol amount |
male |
91 days
| 7 |
|
218.0 |
mg/dl |
26.0 |
68.79 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
101942 |
2644 |
SS.ZUC-Leprfa-/-/Slc |
serum total cholesterol level |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood cholesterol amount |
male |
91 days
| 7 |
|
200.33 |
mg/dl |
44.7 |
118.27 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
101943 |
2644 |
WKY |
serum total cholesterol level |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood cholesterol amount |
male |
0 days
| 10 |
|
65.0 |
mg/dl |
5.0 |
15.81 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
100403 |
2479 |
F344.OLETF-(D8Rat58-D8Mgh17)/Tj |
serum total cholesterol level |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
blood cholesterol amount |
male |
217 days
| 20 |
|
59.7 |
mg/dl |
2.8 |
12.52 |
serum total cholesterol measurement test |
|
0 |
|
0 |
|
|
|
66181 |
716 |
SS/JrTol |
serum total cholesterol level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood cholesterol amount |
male |
140 days
| 6 |
|
114.9 |
mg/dl |
4.3 |
10.53 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
67975 |
834 |
F344.ZUC-Leprfa/Tj |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
10 |
|
426.24 |
mg/dl |
30.04 |
94.99 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
97748 |
1918 |
F344/DuCrlCrlj |
serum total cholesterol level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood cholesterol amount |
male |
185 days
| 9 |
|
81.85 |
mg/dl |
1.93 |
5.79 |
serum total cholesterol measurement test |
tail vein |
|
|
0 |
|
Vitros CHOL slides (Johnson & Johnson, Rochester, NY) |
|
11473 |
85 |
ExHC/Seac |
serum total cholesterol level |
controlled cholesterol content diet (1 %) (for 14 days) and controlled olive oil content diet (10 %) (for 14 days) |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood cholesterol amount |
male |
42 days
| 7 |
|
453.0 |
mg/dl |
23.8 |
62.97 |
serum total cholesterol measurement test |
|
|
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
|
13141 |
71 |
WKY/Izm |
serum total cholesterol level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood cholesterol amount |
male |
91 days
| 5 |
|
75.68 |
mg/dl |
3.09 |
6.91 |
serum total cholesterol measurement test |
|
0 |
|
0 |
|
|
|
64852 |
115 |
WKY/Izm |
serum total cholesterol level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood cholesterol amount |
female |
91 days
| 5 |
|
77.99 |
mg/dl |
1.16 |
2.59 |
serum total cholesterol measurement test |
|
0 |
|
0 |
|
|
|
64855 |
115 |
SHR/NHsdMco |
serum total cholesterol level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood cholesterol amount |
male |
140 days
| 6 |
|
47.3 |
mg/dl |
7.6 |
18.62 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
67976 |
834 |
BN-Lx/Cub |
serum total cholesterol level |
controlled cholesterol content diet (2 %) (for 28 days) and controlled olive oil content diet (5 %) (for 28 days) then fasting (for 16 hours) |
Bottger A, et al., J Clin Invest 1996 Aug 1;98(3):856-62 |
blood cholesterol amount |
not specified |
77 days
| 4 |
|
120.85 |
mg/dl |
2.32 |
4.63 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
68926 |
1030 |
F344/NSlc |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
7 |
|
45.77 |
mg/dl |
4.03 |
10.66 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
97746 |
1918 |
FHH/EurMcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
168 days
| 6 |
|
102.0 |
mg/dl |
9.7 |
23.76 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
99505 |
2318 |
SS.ZUC-Leprfa-/-/Slc |
serum total cholesterol level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood cholesterol amount |
male |
126 days
| 7 |
|
371.14 |
mg/dl |
39.21 |
103.74 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
101920 |
2642 |
WKY/Izm |
serum total cholesterol level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (for 70 days) then fasting |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood cholesterol amount |
male |
98 days
| 10 |
|
73.3 |
mg/dl |
2.34 |
7.4 |
serum total cholesterol measurement test |
|
|
|
0 |
|
|
|
12495 |
263 |
OLETF |
serum total cholesterol level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood cholesterol amount |
male |
246 days
| 23 |
|
90.1 |
mg/dl |
2.2 |
10.56 |
serum total cholesterol measurement test |
carotid artery |
|
|
0 |
|
Cholesterol E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan |
|
12352 |
248 |
SHRSP/A3N |
serum total cholesterol level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood cholesterol amount |
male |
120 days-140 days |
10 |
|
139.0 |
mg/dl |
4.0 |
12.65 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
107625 |
3093 |
FHH/EurMcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
56 days
| 6 |
|
70.0 |
mg/dl |
4.7 |
11.51 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
99501 |
2318 |
FHH/EurMcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
112 days
| 6 |
|
84.0 |
mg/dl |
7.9 |
19.35 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
99503 |
2318 |
FHH-Nr4a1m1Mcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
168 days
| 6 |
|
283.0 |
mg/dl |
29.4 |
72.01 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
99506 |
2318 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum total cholesterol level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood cholesterol amount |
male |
185 days
| 10 |
|
89.19 |
mg/dl |
3.09 |
9.77 |
serum total cholesterol measurement test |
tail vein |
|
|
0 |
|
Vitros CHOL slides (Johnson & Johnson, Rochester, NY) |
|
11477 |
85 |
ExHC/Seac |
serum total cholesterol level |
control condition |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood cholesterol amount |
male |
28 days
| 7 |
|
84.0 |
mg/dl |
2.7 |
7.14 |
serum total cholesterol measurement test |
|
|
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
|
13137 |
71 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum total cholesterol level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood cholesterol amount |
male |
218 days
| 11 |
|
72.7 |
mg/dl |
2.13 |
7.06 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
|
12793 |
311 |
WKY/Izm |
serum total cholesterol level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood cholesterol amount |
male |
119 days
| 10 |
|
60.4 |
mg/dl |
1.04 |
3.3 |
serum total cholesterol measurement test |
|
|
|
0 |
|
|
|
12504 |
263 |
F344/NRrrc |
serum total cholesterol level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood cholesterol amount |
male |
246 days
| 21 |
|
56.33 |
mg/dl |
2.29 |
10.5 |
serum total cholesterol measurement test |
carotid artery |
|
|
0 |
|
Cholesterol E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan |
|
12371 |
248 |
WOKW |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood cholesterol amount |
female |
196 days-224 days |
12 |
serial mean |
84.94 |
mg/dl |
|
|
serum total cholesterol measurement test |
ophthalmic venous plexus |
|
|
0 |
|
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
12425 |
251 |
SHRSP/A3 |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
male |
112 days
| 5 |
|
50.22 |
mg/dl |
0.9 |
2.02 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
68955 |
1033 |
SS.SHR-(D2Rat61-D2Mco18)/Mco |
serum total cholesterol level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood cholesterol amount |
male |
140 days
| 6 |
|
97.3 |
mg/dl |
1.7 |
4.16 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
67977 |
834 |
F344.ZUC-Leprfa/Tj |
serum total cholesterol level |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
blood cholesterol amount |
male |
175 days
| 7 |
|
380.95 |
mg/dl |
26.3 |
69.58 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
T-Cho-E test kit (Wako Chem. LTD) |
|
98080 |
1978 |
SS.ZUC-Leprfa+/+/Slc |
serum total cholesterol level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood cholesterol amount |
male |
126 days
| 6 |
|
116.25 |
mg/dl |
11.59 |
28.39 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
101919 |
2642 |
SS.ZUC-Leprfa-/-/Slc |
serum total cholesterol level |
vehicle control condition (0.5 %) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood cholesterol amount |
male |
91 days
| 6 |
|
333.0 |
mg/dl |
15.6 |
38.21 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
101941 |
2644 |
SHRSP/A3N |
serum total cholesterol level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood cholesterol amount |
female |
120 days-140 days |
15 |
|
147.0 |
mg/dl |
4.0 |
15.49 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
107627 |
3093 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum total cholesterol level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood cholesterol amount |
male |
185 days
| 10 |
|
85.71 |
mg/dl |
1.93 |
6.1 |
serum total cholesterol measurement test |
tail vein |
|
|
0 |
|
Vitros CHOL slides (Johnson & Johnson, Rochester, NY) |
|
11475 |
85 |
BN/Seac |
serum total cholesterol level |
controlled cholesterol content diet (1 %) (for 14 days) and controlled olive oil content diet (10 %) (for 14 days) |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood cholesterol amount |
male |
42 days
| 11 |
|
211.0 |
mg/dl |
8.9 |
29.52 |
serum total cholesterol measurement test |
|
|
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
|
13145 |
71 |
F344/NSlc |
serum total cholesterol level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood cholesterol amount |
male |
218 days
| 7 |
|
69.7 |
mg/dl |
1.77 |
4.68 |
serum total cholesterol measurement test |
|
0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
|
12775 |
311 |
MWF-Chr 6SHR/Rkb |
serum total cholesterol level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood cholesterol amount |
not specified |
168 days
| 19 |
|
74.52 |
mg/dl |
2.32 |
10.1 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
serum triglyceride analysis |
|
65390 |
117 |
WKY/Izm |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
male |
112 days
| 5 |
|
72.54 |
mg/dl |
1.54 |
3.45 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
some flavor of WKY |
68957 |
1033 |
F344/NSlc |
serum total cholesterol level |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
blood cholesterol amount |
male |
217 days
| 9 |
|
52.4 |
mg/dl |
5.7 |
17.1 |
serum total cholesterol measurement test |
|
0 |
|
0 |
|
|
|
66180 |
716 |
SHR/Izm |
serum total cholesterol level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood cholesterol amount |
male |
119 days
| 10 |
|
136.1 |
mg/dl |
10.09 |
31.9 |
serum total cholesterol measurement test |
|
|
|
0 |
|
|
|
12458 |
263 |
SHR/FubRkb |
serum total cholesterol level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood cholesterol amount |
not specified |
168 days
| 10 |
|
61.0 |
mg/dl |
1.93 |
6.1 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
serum triglyceride analysis |
|
65388 |
117 |
WKY/Izm |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
female |
112 days
| 5 |
|
80.6 |
mg/dl |
2.45 |
5.48 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
some flavor of WKY |
68958 |
1033 |
SHR/OlaIpcv |
serum total cholesterol level |
controlled cholesterol content diet (2 %) (for 28 days) and controlled olive oil content diet (5 %) (for 28 days) then fasting (for 16 hours) |
Bottger A, et al., J Clin Invest 1996 Aug 1;98(3):856-62 |
blood cholesterol amount |
not specified |
77 days
| 5 |
|
77.61 |
mg/dl |
2.7 |
6.04 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
68927 |
1030 |
F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj |
serum total cholesterol level |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
blood cholesterol amount |
male |
175 days
| 5 |
|
339.97 |
mg/dl |
29.35 |
65.63 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
T-Cho-E test kit (Wako Chem. LTD) |
|
98081 |
1978 |
WKY |
serum total cholesterol level |
controlled enalapril content drinking water (50 mg/l) (for 26 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood cholesterol amount |
male |
0 days
| 10 |
|
360.0 |
mg/dl |
45.0 |
142.3 |
serum total cholesterol measurement test |
|
0.0 |
PA IV 50mg/kg |
19 |
days |
|
|
100405 |
2479 |
SHRSP/A3N |
serum total cholesterol level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood cholesterol amount |
female |
120 days-140 days |
24 |
|
98.0 |
mg/dl |
1.0 |
4.9 |
serum total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
107626 |
3093 |